z-logo
Premium
Sodium–glucose co‐transporter 2 inhibitors: strength of evidence for a cardio‐renal‐metabolic therapy
Author(s) -
Parcha Vibhu,
Arora Pankaj
Publication year - 2021
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.2172
Subject(s) - empagliflozin , medicine , dapagliflozin , canagliflozin , heart failure , albuminuria , diabetes mellitus , type 2 diabetes mellitus , cardiology , type 2 diabetes , blood pressure , endocrinology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom